Applied Biocode Corporation (6598)
TWSE TWSE Primary Summary
6598 Chart
Applied Biocode Corporation Dividends
Applied Biocode Corporation Earnings
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 13 Mar 2025 Date | | - Cons. EPS | - EPS |
| 6 Nov 2024 Date | | - Cons. EPS | - EPS |
| 26 Aug 2024 Date | | - Cons. EPS | - EPS |
| 22 Aug 2024 Date | | - Cons. EPS | - EPS |
| 12 May 2025 Date | | - Cons. EPS | - EPS |
| 13 Mar 2025 Date | | - Cons. EPS | - EPS |
| 6 Nov 2024 Date | | - Cons. EPS | - EPS |
| 26 Aug 2024 Date | | - Cons. EPS | - EPS |
| 22 Aug 2024 Date | | - Cons. EPS | - EPS |
Applied Biocode Corporation (6598) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Applied Biocode Corporation ever had a stock split?
Applied Biocode Corporation Profile
| Medical Devices Industry | Healthcare Sector | Dr. Winston Z. Ho Ph.D. CEO | TWSE Exchange | KYG0488D1051 ISIN |
| TW Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Based in Santa Fe Springs, California, Applied BioCode Corporation is at the forefront of developing and commercializing multiplex diagnostic testing products tailored for the healthcare industry. The company specializes in providing advanced solutions for molecular diagnostics through automation and innovative technology. Its commitment is towards enhancing diagnostic capabilities, aiming to ensure faster, more accurate testing processes that cater to various medical and research needs.
Products and Services
- BioCode MDx 3000 System
An automated molecular diagnostic system that revolutionizes the process of PCR amplification, hybridization, and detection steps essential in molecular testing. This product streamlines the workflow in labs, offering a blend of automation, efficiency, and precision in testing.
- BioCode 2500 Analyzer
A sophisticated system designed to read barcoded magnetic beads (BMB), showcasing the barcode and fluorescence intensity for individual beads. This technology facilitates a novel approach in diagnostics, ensuring detailed and accurate analysis.
- BioCode SARS-CoV-2 Assay
A highly sensitive nucleic acid assay developed for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs. This assay is critical in the ongoing battle against the COVID-19 pandemic, providing reliable results essential for managing and controlling the spread of the virus.
- CoV-2 Flu Assay
An innovative RNA assay designed for the concurrent detection of various strains of Influenza alongside SARS-CoV-2, enhancing the capability to diagnose and differentiate between these viral infections efficiently.
- Gastrointestinal and Respiratory Pathogen Panel
Applied BioCode extends its product range to include comprehensive assays for the detection of pathogens causing gastrointestinal and respiratory infections. These panels are crucial for timely diagnosis and treatment of infectious diseases.
- General Purpose Reagents and Fungal Analyte Specific Reagents
The company also provides a variety of general-purpose reagents and manufactures 28 specific reagents for the identification of fungal analytes. These products underscore the company’s dedication to broadening its diagnostic capabilities.
- Barcoded Bead Related Accessories
In addition to its main products, Applied BioCode offers an array of barcoded bead-related accessories, further supporting the utility and applicability of its diagnostic solutions in laboratory settings.
Contact Information
